newsfilter
← Latest News
GlobeNewswire·

INmune Bio to Detail XPro1595 Registrational Strategy in Upcoming Alzheimer's Webinar

Boca Raton, FL, Feb. 23, 2026 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ:INMB) ("INmune" or the "Company"), a late-stage biotechnology company focused on inflammation and immunology, will host a webinar focused on